A picture of spheroids in droplet

Accelerating 3D Cell Model Generation

Generate highly uniform 3D cell models, including cancer spheroids, embryoid bodies and organoids, with speed, reproducibility and minimal starting material

3D cell models have become indispensable tools for drug discovery, disease modelling and regenerative medicine. OneFlow™ combines droplet microfluidics with automated cell aggregation to rapidly generate highly uniform 3D cell models at very high throughput.

By precisely controlling cell encapsulation and aggregation inside nano-droplets, the platform provides a reproducible starting point for downstream differentiation, organoid generation and functional assays.

From Cells to 3D Cell Models

OneFlow™ streamlines the generation of high-quality 3D cell models through a rapid and automated droplet microfluidics workflow. Cells are encapsulated in precisely controlled nano-droplets, where they rapidly aggregate into highly uniform spheroids or embryoid bodies before gentle recovery for downstream differentiation, organoid generation or functional screening.

Multiple 3D Cell Models. One Platform.

OneFlow™ supports multiple 3D cell model generation workflows on a single integrated platform, enabling the rapid production of homogeneous spheroids, embryoid bodies and organoids.

Spheroids

Generate highly uniform spheroids from cancer cell lines, primary cells and patient-derived samples for applications including drug discovery, oncology, toxicology and disease modelling.

Embryoid Bodies

Produce homogeneous embryoid bodies from iPSCs, providing a robust starting point for downstream differentiation into hematopoietic and immune cell lineages.

Organoids

Generate highly uniform precursor aggregates that support robust and reproducible organoid development for stem cell research, disease modelling and regenerative medicine.